Canada markets close in 5 hours 9 minutes

JNJ Jan 2025 155.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
7.22+0.85 (+13.34%)
As of 10:27AM EDT. Market open.
Full screen
Loading interactive chart...
  • Zacks

    Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

    Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

  • Reuters

    Pharma aims to deliver personalized cancer therapies more quickly

    Big pharmaceutical companies that make personalized blood cancer treatments are working to cut the manufacturing turnaround time by as much as half in coming years, as they try to deliver them sooner in a patient's disease course. These treatments known as CAR-T therapies are used for the sickest patients for whom standard treatments have failed. Gilead Sciences, Novartis, Johnson & Johnson, and Bristol Myers Squibb have made billions from their treatments, which can extend lives by months or years for patients with aggressive advanced cancers.

  • Zacks

    Time for Healthcare ETFs?

    Compelling valuation, innovation in specific growth areas and an aging population as well as increasing healthcare spending are the tailwinds of the medical sector.